CPH · STRAP.CO
Strategic Partners A/S
DKK 635.00-DKK 15.00 (-2.31%)
Strategic Partners A/S’s quoted price sits in the lower half of its reported 52-week range, 32.88% below the high.
Loading market information…
OTC · NNLX · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NanoLogix, Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting with organic, inorganic molecules, and proteins. Another significant product is the FlatPack Petri Plate, essential for the isolation and cultivation of diverse microorganisms, including both fastidious and non-fastidious types, as well as those requiring or not requiring oxygen for growth (aerobic and anaerobic respectively). The company's solutions are applied across a broad spectrum of sectors, including medical diagnostics, national defense, homeland security initiatives, pharmaceutical research and manufacturing, industrial processes, veterinary science, and environmental monitoring. NanoLogix serves an established clientele comprising prominent medical and scientific organizations. This includes laboratories, healthcare institutions, academic universities, various businesses, and specialized research establishments. Headquartered in Hubbard, Ohio, NanoLogix, Inc. operates from this location.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
DKK 635.00-DKK 15.00 (-2.31%)
Strategic Partners A/S’s quoted price sits in the lower half of its reported 52-week range, 32.88% below the high.
$0.03+$0.03 (+26,900.0%)
Vaxxinity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.5% below the high.
$0.00+$0.00 (0.0%)
PaxMedica, Inc. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 96.5% below the high.
$0.00-$0.00 (0.0%)
Q BioMed Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
$0.00$0.00 (0.0%)
HEALTHeUNIVERSE, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Trevena, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.26% below the high.
$0.00$0.00 (0.0%)
Infinity Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.15% below the high.
$0.00$0.00 (0.0%)
Aridis Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
